Process Engineering STREAM
-
Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.
10/20/2025
In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.
-
Take The Lead With The Gibco CHOvantageâ„¢ GS Cell Line Development Kit
3/13/2026
See how this kit accelerates clone development to 14 weeks with ≥7 g/L protein titers while reducing costs through royalty-free commercial licensing for therapeutic applications.
-
OsmoTECH® HT Automated Micro-Osmometer
12/14/2021
The automation-friendly OsmoTECH HT, the only plate-based micro-osmometer, is designed in a 96 well format that ensures efficiency and acceleration of osmolality testing in early upstream process development, formulation development and stability testing.
-
Accelerating Novel Cell Therapies To Market
3/20/2024
Learn about two matrices that, when combined, provide an optimal solution for the process development and manufacturing of novel induced pluripotent stem cell therapies.
-
Collaboration & Expertise, The Keys To Efficiency And Scalability Across All Modalities
7/8/2022
View this video and discover our global vaccine capabilities from process development to full-scale GMP-manufacturing and in all modalities.
-
Small-Scale Oligonucleotide Synthesizer That Supports Scale Up
2/16/2023
Learn about a small oligonucleotide synthesizer with big impact that features a user-friendly interface, compact footprint, and more. This small scale system is user friendly and supports scale up.
-
Nanoassemblr Blaze mRNA Vaccine Demo
4/13/2022
NxGen Technology delivers a scalable means to perform the critical particle formation step in a nanomedicine development process.
-
How To Best Optimize mRNA Production Workflows
4/11/2023
Multiple steps in the mRNA manufacturing process can appear more complex than they have to be. Learn how to simplify your approach and produce the best possible mRNA vaccines and therapeutics.
-
A Closed And Automated Solution For Cell Therapy Manufacturing
3/1/2024
Streamline your cell therapy manufacturing process and workflow by automating and closing your cell isolation, cell harvest, and formulation with a system designed to offer you versatility.
-
Engineering Bacterial Vector-Based Immunotherapies With OS Therapies' Paul Romness and Robert Petit, Ph.D.
10/7/2025
In this episode of “Better Biopharma,” host Tyler Menichiello is joined by OS Therapies’ CEO, Paul Romness, and chief medical and scientific officer, Robert Petit, Ph.D. The three discuss the development and manufacturing of the company’s lead asset, OST-HER2, a Listeria-based immunotherapy for osteosarcoma.